Dhruv Mahtta

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs”.

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Diabetes Care(2022)10.2337/dc21-1815

N/A

6.5DataRank · unranked

132 citations

David J. Ramsey, Michelle Lee, Liang Chen, Mahmoud Al Rifai, Julia M. Akeroyd +10 more

Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease

The American Journal of Medicine(2021)10.1016/j.amjmed.2021.02.029

N/A

0.520DataRank · unranked

31 citations

Dhruv Mahtta, Liang Chen, Aliza Hussain, Mahmoud Al Rifai, Preetika Sinh +6 more

A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

Current Cardiology Reports(2022)10.1007/s11886-022-01694-5

N/A

0DataRank · unranked

6 citations

Dhruv Mahtta, Sankar D. Navaneethan, Elizabeth M. Vaughan, Ajar Kochar, Martha Gulati +4 more